Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.7K
Overview
85.7K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation.

Blood advances·2026
Same author

Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

Blood advances·2026
Same author

A pilot randomized clinical trial of a peer support intervention for hematopoietic stem cell transplantation.

Blood advances·2026
Same author

Supportive care interventions in hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Blood advances·2026
Same author

How I select hematopoietic cell donors in the era of posttransplant cyclophosphamide.

Blood·2026
Same author

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease.

Blood advances·2026

Related Experiment Video

Updated: Mar 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K

Classification systems for chronic graft-versus-host disease.

Stephanie J Lee1

  • 1Fred Hutchinson Cancer Research Center, Seattle, WA.

Blood
|November 9, 2016
PubMed
Summary

Chronic graft-versus-host disease (GVHD) is a serious complication of stem cell transplants, causing multiorgan dysfunction. This review summarizes NIH consensus criteria for classifying chronic GVHD, aiding clinical research and care.

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality following allogeneic hematopoietic cell transplantation.
  • It is characterized by pleiotropic, multiorgan inflammation and fibrosis, potentially leading to permanent organ dysfunction.
  • The underlying cause involves donor immune cells replacing the host immune system, with patient, donor, and transplant factors influencing disease presentation.

Purpose of the Study:

  • To summarize the National Institutes of Health (NIH) Consensus Development Project recommendations for chronic GVHD classification.
  • To illustrate the application of these standardized criteria in clinical research.
  • To explore the potential utility of these criteria in routine clinical care.

Main Methods:

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.7K
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

10.3K

Related Experiment Videos

Last Updated: Mar 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.7K
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

10.3K
  • Review of the 2005 and 2014 NIH Consensus Development Projects on Criteria for Clinical Trials in Chronic GVHD.
  • Analysis of how these recommendations have been implemented in clinical research settings.
  • Discussion of the translation of these criteria from research to clinical practice.

Main Results:

  • Standardized terminology and classification systems for chronic GVHD have been established by NIH consensus.
  • These criteria facilitate a common language and consistent procedures for clinical research.
  • The review highlights the ongoing use and potential expansion of these criteria in clinical settings.

Conclusions:

  • The NIH consensus criteria provide a standardized framework for chronic GVHD research.
  • Consistent application of these criteria improves the reliability and comparability of clinical research findings.
  • Further integration of these standardized criteria into clinical practice may enhance patient care and outcomes.